Comunicación Nº: 009 English version English version

Síndrome de Sêzary con intensa afectación ganglionar.

Margarita Delgado Portela, Miguel Angel Piris Pinilla*, Helíades Portillo Pérez-Olivares**, Marcial García Rojo, Jesús González García, Francisco Martín Dávila, Rafael López Pérez, Manuel Carbajo Vicente, Ana Puig Rullán.

[Título] [Introducción] [Material y Métodos] [Resultados] [Iconografía] [Discusión]




1.- Cerroni L, Rieger E, Hödl S, and Kerl H. Clinicopathologic and immunologic features associated with transformation of Mycosis fungoides to large-cell lymphoma. Am. J. Surg. Pathol 16(6): 543-552, 1992.

2.- Harris NL, Jaffe ES, Banks PM and Chan John KC. A revised European-American clasification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 84 (5): 1361-1392, 1994.

3.- Ioachim HL. Lymph node pathology. Second Idition. J.B Lippincott Company.pp 481-487, Philadephia 1.993.

4.- Lynch JW Jr., Linoilla I , Sausville EA, Steinberg SM, Ghosh BC, Nguyen DT, Schechter GP, Fischman AB, Ihde DC, Stocker JL, Bastian A, Turner R, Cotelingam JD, Gazdar AF, and Foss FM. Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in Mycosis Fungoides. Blood, 79 (12): 3293-9, 1.992.

5.- Nathwani BN. A critical analysis of the classifications of non-Hodgkin’s lymphomas. Cancer, 44: 347-384, 1.979.

6.- Sausville EA, Vorshan GF, Mathews MJ, Makuch RW, Fischmann AB, Schechter GP, Gazdar AF and Bunn PA. Histologic assessment of lymph nodes in Mycosis Fundoides/Sezary Syndrome (cutaneons T-cell lymphoma): Clínical correlations and prognostic import of a new classification System. Human. Pathol. 16: 1098-1109, 1.985.

7.- Sausville EA, Eddy JL, Makuch RW, Fischmann AB, Schechter GP, Matthews M, Glatstein E, Ihde DC, Kaye F, Veach SR, Phelps R, O’Connor T, Trepel JB, Cotelingam JD, Gazdar AF, Minna JA and Bunn PA. Histopathologic Staging at initial diagnosis of Mycosis Fungoides and the Sézary Syndrome. Definition of three distintive prognostic groups. Ann. Intern. Med. 109: 372-82, 1.988.

8.- Scheffer E, Meijer CJLM, Van Vloten W and Willeuze R. A histologic study of lymph nodes from patients with the Sezary Syndrome. Cancer 57: 2375- 2380, 1.986.

9.- Scheffer E, Meijer CJLM and Van Vloten WA. Dermatopathic lymphadenopathy and lymph node involvement in Mycosis Fungoides. Cancer, 45: 137-148, 1.980.

10.- Vonderheid EC, Diamond LW, Van Vloten WA, Scheffer E, Meijer CJLM, Cashell AW, Hardman JM, Lai S-M, Hermans J and Mathews MJ. Lymph node classification Systems in cutaneons T-cell lymphoma. Evidence for the utility of the Working Formulation of non-Hodgkin`s Lymphomas for clinical usage. Cancer 73: 207-218, 1.994.

11.- Vonderheid EC, Diamond LW, Lai SM; AU F., and Dellavecchia MA. Lymph node histopathologic findings in cutaneous T-cell lymphoma. A. prognostic classification system based on morphologic assessment. Am. J. Clin. Pathol. 97: 121-129, 1.992.

12.- Weiss LM, Hu E, Wood GS, Moulds C, Cleary ML, Warnke R, and Sklar J. clonar rearrangements of T-cell receptor genes in Mycosis Fungoides and dermatopathic lymphadenopathy. N.Eng. J. Med. 313: 539-544, 1.985.

13.- Wolff-Sneedorffa A, Analyses of T-cell receptor beta- chain genes by Southern blotting in known and suspected cutaneous T-cell lymphoma. A Study of 67 samples from 32 patients. Clin. Exp. Dermatol. 20:2, 115-122, 1.995